Skip to main content
Clinical Trials/NCT04672265
NCT04672265
Active, not recruiting
Not Applicable

A Randomized Trial to Increase Access to Breast Cancer Screening by Invitation Language Among Immigrants in Norway

Oslo University Hospital1 site in 1 country11,355 target enrollmentApril 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer Screening
Sponsor
Oslo University Hospital
Enrollment
11355
Locations
1
Primary Endpoint
Screening attendance
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The investigators aim to test whether inviting immigrants to breast cancer screening with a letter in their mother tongue in addition to the standard letter in Norwegian changes screening uptake in these immigrant groups, compared with a comparable group who receive the invitation in Norwegian only,

Detailed Description

Women in selected immigrant groups according to birth country will be invited to screening and randomized in a 1:1 ratio to receive the screening invitation and information material 1) in the major official native language in the country the invitee is born in addition to Norwegian (intervention group), or 2) only Norwegian (control). The 13 selected countries of origin are Poland, the Philippines, Pakistan, Somalia and Arabic speaking countries (Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia). The five intervention languages will thus be Polish, English, Urdu, Somali and Arabic.

Registry
clinicaltrials.gov
Start Date
April 15, 2021
End Date
December 31, 2030
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Paula Berstad

Researcher

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Invited to screening program during the study recruitment period (January 2021-June 2022)
  • The registered country of birth of the invitee is one of the following; Poland, Pakistan, Philippines, Somalia, Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia

Exclusion Criteria

  • Not reached with the screening invitation letter because of wrong address or similar

Outcomes

Primary Outcomes

Screening attendance

Time Frame: 0-6 months after sent screening invitation letter

Attendance in breast cancer screening programme (yes/no)

Study Sites (1)

Loading locations...

Similar Trials